U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07338357) titled 'Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML' on Dec. 22, 2025.
Brief Summary: A study to evaluate the safety and preliminary efficacy of CLL-1-targeted CAR-T cell therapy in children aged 3 to 18 years with relapsed or refractory acute myeloid leukemia (r/r AML).
Study Start Date: Jan. 05
Study Type: INTERVENTIONAL
Condition:
AML (Acute Myeloid Leukemia)
CAR-T
Intervention:
BIOLOGICAL: CAR-T
A infusion of CLL-1 CAR-T cells following a lymphodepleting chemotherapy regimen.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: First Affiliated Hospital of Guangxi Medical University
Information provided ...